The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson and Johnson shot may not be seen as equal to... ...https://economictimes.indiatimes.com/news/international/world-news/third-us-vaccine-could-raise-question-which-shots-are-best/articleshow/81231875.cms
Food and Drug Administration scientists on Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe... ...https://economictimes.indiatimes.com/news/international/business/usfda-says-single-dose-shot-from-jj-prevents-severe-covid/articleshow/81201869.cms
The Office of New Drugs (OND) of the US Food and Drug Administration (FDA) has denied the company's appeal of the Complete Response Letter (CRL) in... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-rules-against-sun-pharma-advanced-research-cos-appeal-regarding-cancer-drug-application/articleshow/81174716.cms
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in the... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-generic-droxidopa-capsules/articleshow/81106354.cms
Posted by Equitymaster Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 117 points, down 0.2% at... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/dxKDJlu6QVw/tm.asp
An additional reason precisely why...